COMP <GO>
TGEN vs CBAT // FORWARD P/E MULTIPLE
Tecogen Inc. (NYSE) VS. CBAK Energy Technology Limited (NASDAQ) • 15-METRIC TALLY: TGEN 0
— CBAT 2
■ METRIC PARITY
LAST: $1.99 (-14.59%) • MKT CAP: $70.3M
forward-pe
—
LAST: $1.11 (+13.18%) • MKT CAP: $86.9M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TGEN VS. CBAT)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TGEN | CBAT | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 36.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -14.66% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -30.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -30.50% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 19.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.24 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 35.9 | 56.0 | -20.12 | CBAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $70.3M | $86.9M | -$16.6M | CBAT | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TGEN REV | CBAT REV | TGEN GROSS % | CBAT GROSS % | TGEN FCF | CBAT FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $27.1M | — | 36.3% | — | -$10.3M | — |
| FY 2024 | $22.6M | — | 43.6% | — | $3.1M | — |
| FY 2023 | $25.1M | — | — | — | -$817.8K | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TGEN // BETA —
CBAT // BETA —